Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
Clinical trial NCT05645380 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05645380
- Sponsor
- University of Kansas Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-05
- Primary completion
- 2026-12-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.